Better Therapeutics, Inc. (BTTX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 28, 2026
Better Therapeutics Market Cap
Better Therapeutics has a market cap or net worth of $5.45 thousand as of October 30, 2026. It is the 52,037th most valuable company in the world and the 8,017th biggest in the United States.
Market Cap
5.45K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,017 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since March 17, 2021, Better Therapeutics's market cap has decreased from 66.05M to 5.45K, a decrease of -99.99%. That is a compound annual growth rate of -81.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 55.00 | -98.99% |
| Dec 31, 2025 | 5.45K | - |
| Dec 31, 2024 | 5.45K | -99.94% |
| Dec 29, 2023 | 9.24M | -64.77% |
| Dec 30, 2022 | 26.24M | -76.09% |
| Dec 31, 2021 | 109.74M | 66.14% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardax | 83.00 |
| 0913693 B.C. | 74.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Genocea Biosciences | 59.00 |
| Panacos Pharmaceuticals | 54.00 |
| Iterum Therapeutics | 53.00 |
| Baudax Bio | 52.00 |